Accessibility Menu
 
Catalent logo

Catalent

(NYSE) CTLT

Current PriceN/A
Market CapN/A
Since IPO (2014)+218%
5 Year+15%
1 Year+52%
1 Month+7%

Catalent Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$4.42B

Net Income (TTM)

$413.00M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

CTLT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Catalent

Industry

Pharmaceuticals

Employees

16,900

CEO

Alessandro Maselli

Headquarters

Somerset, NJ 08873, US

CTLT Financials

Key Financial Metrics (TTM)

Gross Margin

22%

Operating Margin

-17%

Net Income Margin

-24%

Return on Equity

-25%

Return on Capital

-9%

Return on Assets

-11%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$953.00M

Operating Income

$749.00M

EBITDA

$284.00M

Operating Cash Flow

$268.00M

Capital Expenditure

$327.00M

Free Cash Flow

$59.00M

Cash & ST Invst.

$289.00M

Total Debt

$4.92B

Catalent Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$1.02B

+4.2%

Gross Profit

$181.00M

+0.0%

Gross Margin

17.69%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

17,000

N/A

Net Income

$129.00M

+82.0%

EBITDA

$56.00M

+108.9%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Net Cash

$4.61B

+2.6%

Accounts Receivable

$1.46B

+4.4%

Inventory

$553.00M

-31.8%

Long Term Debt

$4.89B

+13.0%

Short Term Debt

$61.00M

-90.4%

Return on Assets

-10.69%

N/A

Return on Invested Capital

-8.59%

N/A

Free Cash Flow

$4.00M

+102.6%

Operating Cash Flow

$61.00M

+187.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KRTXKaruna Therapeutics, Inc.
$329.83+0.03%
WBAWalgreens Boots Alliance, Inc.
$11.98+0.50%
ITCIIntra-Cellular Therapies, Inc.
$131.87+0.00%
OSHOak Street Health, Inc.
$39.00+0.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About CTLT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.